Relationship of Cholelithiasis and Urolithiasis with Methylenetetrahydrofolate Reductase Polymorphisms
AIM: To investigate the relationship of cholelithiasis and urolithiasis with Methylenetetrehydrofolate Reductase (MTHFR) polymorphism(s) in patients with poor obstetric history to search whether they are risk factors for adverse pregnancy outcome.
MATERIALS AND METHOD: This study is consisted of 94 patients with poor obstetric history. Patients were evaluated in terms of the presence of cholelithiasis and urolithiasis in association with MTHFR polymorphism(s). Additional laboratory tests including homocysteine measurements were also performed. ROC analysis for assessing the performance of blood homocysteine level in predicting the presence of cholelithiasis and urolithiasis were also performed.
RESULTS: Patients were divided into three groups such as cholelithiasis group (n = 9, 9.6%), urolithiasis group (n = 18, 19.1%) and control group (n = 67, 71.3%). Groups did not differ in term of age and Beksac obstetrics index (BOI) which is "[living child+(π/10)]/gravidity." The rate of the presence of MTHFR polymorphisms were 88.9% (8/9), 88.9% (16/18) and 43.3% (29/67) in cholelithiasis, urolithiasis and control groups respectively. Median homocysteine levels were found to be 13.1, 11.6 and 7.2 micromol/lt for the groups respectively. Statistically significant differences were found for MTHFR polymorphism rates and homocysteine levels (<0.001 for both). According to ROC analysis, 10.9 mcmol/L (88.9% sensitivity, 89.6% specificity) and 9.25 mcmol/L (83.3% sensitivity, 73.1% specificity) were determined to be cutoff values of homocysteine for cholelithiasis and urolithiasis respectively.
CONCLUSION: More frequent MTHFR polymorphisms are observed in women with a clinical history of gall or renal stones. Thus, screening of these patients may be benefical for the approprate management of their subsequent pregnancies.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
|---|---|
| Enthalten in: |
Journal of investigative surgery : the official journal of the Academy of Surgical Research - 34(2021), 10 vom: 10. Okt., Seite 1104-1107 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Beksac, Kemal [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cholelithiasis |
|---|
| Anmerkungen: |
Date Completed 01.11.2021 Date Revised 27.04.2022 published: Print-Electronic CommentIn: J Invest Surg. 2020 Apr 15;:1-2. - PMID 32290708 Citation Status MEDLINE |
|---|
| doi: |
10.1080/08941939.2020.1742402 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM308137531 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM308137531 | ||
| 003 | DE-627 | ||
| 005 | 20231225131110.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/08941939.2020.1742402 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1027.xml |
| 035 | |a (DE-627)NLM308137531 | ||
| 035 | |a (NLM)32228104 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Beksac, Kemal |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Relationship of Cholelithiasis and Urolithiasis with Methylenetetrahydrofolate Reductase Polymorphisms |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.11.2021 | ||
| 500 | |a Date Revised 27.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: J Invest Surg. 2020 Apr 15;:1-2. - PMID 32290708 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a AIM: To investigate the relationship of cholelithiasis and urolithiasis with Methylenetetrehydrofolate Reductase (MTHFR) polymorphism(s) in patients with poor obstetric history to search whether they are risk factors for adverse pregnancy outcome | ||
| 520 | |a MATERIALS AND METHOD: This study is consisted of 94 patients with poor obstetric history. Patients were evaluated in terms of the presence of cholelithiasis and urolithiasis in association with MTHFR polymorphism(s). Additional laboratory tests including homocysteine measurements were also performed. ROC analysis for assessing the performance of blood homocysteine level in predicting the presence of cholelithiasis and urolithiasis were also performed | ||
| 520 | |a RESULTS: Patients were divided into three groups such as cholelithiasis group (n = 9, 9.6%), urolithiasis group (n = 18, 19.1%) and control group (n = 67, 71.3%). Groups did not differ in term of age and Beksac obstetrics index (BOI) which is "[living child+(π/10)]/gravidity." The rate of the presence of MTHFR polymorphisms were 88.9% (8/9), 88.9% (16/18) and 43.3% (29/67) in cholelithiasis, urolithiasis and control groups respectively. Median homocysteine levels were found to be 13.1, 11.6 and 7.2 micromol/lt for the groups respectively. Statistically significant differences were found for MTHFR polymorphism rates and homocysteine levels (<0.001 for both). According to ROC analysis, 10.9 mcmol/L (88.9% sensitivity, 89.6% specificity) and 9.25 mcmol/L (83.3% sensitivity, 73.1% specificity) were determined to be cutoff values of homocysteine for cholelithiasis and urolithiasis respectively | ||
| 520 | |a CONCLUSION: More frequent MTHFR polymorphisms are observed in women with a clinical history of gall or renal stones. Thus, screening of these patients may be benefical for the approprate management of their subsequent pregnancies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cholelithiasis | |
| 650 | 4 | |a MTHFR polymorphisms | |
| 650 | 4 | |a homocysteine | |
| 650 | 4 | |a poor obstetric history | |
| 650 | 4 | |a pregnancy outcome | |
| 650 | 4 | |a urolithiasis | |
| 650 | 7 | |a Methylenetetrahydrofolate Reductase (NADPH2) |2 NLM | |
| 650 | 7 | |a EC 1.5.1.20 |2 NLM | |
| 700 | 1 | |a Tanacan, Atakan |e verfasserin |4 aut | |
| 700 | 1 | |a Cagan, Murat |e verfasserin |4 aut | |
| 700 | 1 | |a Dönmez, Hanife Güler |e verfasserin |4 aut | |
| 700 | 1 | |a Fadiloglu, Erdem |e verfasserin |4 aut | |
| 700 | 1 | |a Unal, Canan |e verfasserin |4 aut | |
| 700 | 1 | |a Beksac, M S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of investigative surgery : the official journal of the Academy of Surgical Research |d 1995 |g 34(2021), 10 vom: 10. Okt., Seite 1104-1107 |w (DE-627)NLM012966584 |x 1521-0553 |7 nnns |
| 773 | 1 | 8 | |g volume:34 |g year:2021 |g number:10 |g day:10 |g month:10 |g pages:1104-1107 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/08941939.2020.1742402 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 34 |j 2021 |e 10 |b 10 |c 10 |h 1104-1107 | ||